100 related articles for article (PubMed ID: 2361635)
1. Induction of labor in intrauterine fetal death with 16-phenoxy-prostaglandin-E2-methylsulfonylamide (sulprostone)--effects on uterine contractility, coagulation and kallikrein-kinin systems.
Laudański T; Litorowicz A; Akerlund M
Gynecol Obstet Invest; 1990; 29(4):269-72. PubMed ID: 2361635
[TBL] [Abstract][Full Text] [Related]
2. Intravenous 16-phenoxy PGE2 methylsulfonylamide for induction of labor in cases of fetal death.
Gulisano AS; Pepe F; Panella M; Privitera CD; Pepe G; Piccione G
Clin Exp Obstet Gynecol; 1987; 14(2):103-5. PubMed ID: 3568394
[TBL] [Abstract][Full Text] [Related]
3. [Uterine activity in induction of labor by vaginal administration of prostaglandin E2 tablets].
Egarter C; Philipp K; Skodler D; Kofler E
Z Geburtshilfe Perinatol; 1986; 190(3):129-32. PubMed ID: 3464139
[TBL] [Abstract][Full Text] [Related]
4. Intravenous prostaglandin E2 and 16-phenoxy prostaglandin E2 methyl sulfonylamide for induction of fetal death in utero.
Gruber WS; Baumgarten K
Am J Obstet Gynecol; 1980 May; 137(1):8-14. PubMed ID: 7369292
[TBL] [Abstract][Full Text] [Related]
5. Effect of prostaglandin E2 on myometrial electrical activity in women undergoing induction of labor.
Aviram A; Melamed N; Hadar E; Raban O; Hiersch L; Yogev Y
Am J Perinatol; 2014 May; 31(5):413-8. PubMed ID: 23918518
[TBL] [Abstract][Full Text] [Related]
6. [Use of a new synthetic prostaglandin (sulprostone) in various obstetrical conditions].
Melis GB; Fruzzetti F; Paoletti AM; Strigini F; Baisi F; Gargiulo T; Pallotti A; Solla E; Sesselego G; Fioretti P
Minerva Ginecol; 1982 Mar; 34(3):183-90. PubMed ID: 7045735
[TBL] [Abstract][Full Text] [Related]
7. [PGF2 and the induction of the trial of labor. The prognostic value of uterine contractions].
Indraccolo SR; Rech F; Lojodice S; Patella A
Minerva Ginecol; 1998 Sep; 50(9):355-8. PubMed ID: 9842202
[TBL] [Abstract][Full Text] [Related]
8. Patterns of uterine activity. Using oxytocin after intracervical PGE2.
Coleman FH; Rayburn WF; Burks LS; Farmer KC; Larson JD; Turnbull GL
J Reprod Med; 1997 Jan; 42(1):44-8. PubMed ID: 9018645
[TBL] [Abstract][Full Text] [Related]
9. [Blood coagulation parameters in prostaglandin-induced labour after intrauterine fetal death (author's transl)].
Gruber W
Wien Klin Wochenschr; 1978 Aug; 90(15):553-6. PubMed ID: 676315
[TBL] [Abstract][Full Text] [Related]
10. [Intracervical prostaglandin E2 as pre-inducer of labor in patients with preterm fetal death].
Garcia-B CQ; Baez-Vasquez B; Rodriguez-Colorado S
Ginecol Obstet Mex; 1996 Jan; 64():21-5. PubMed ID: 8948920
[TBL] [Abstract][Full Text] [Related]
11. [Induction of labor by a prostaglandin analog substitute in cases of intrauterine fetal death].
Herczeg J
Orv Hetil; 1982 May; 123(18):1107-8. PubMed ID: 7088550
[No Abstract] [Full Text] [Related]
12. Effects of nomegestrol acetate on spontaneous and sulprostone-induced uterine contractions in pregnant cynomolgus monkeys monitored by telemetry.
Carbonne B; Cabrol D; Clerget MS; Germain G
Am J Obstet Gynecol; 1998 Jan; 178(1 Pt 1):150-5. PubMed ID: 9465820
[TBL] [Abstract][Full Text] [Related]
13. Effect of prostaglandin E2 and its metabolites on lower segment myometrium in vitro.
Gordon-Wright AP; Elder MG
Eur J Obstet Gynecol Reprod Biol; 1980 Jun; 10(5):297-302. PubMed ID: 7190512
[TBL] [Abstract][Full Text] [Related]
14. [Intravenous administration of prostaglandin F2alpha or prostaglandin E2 in labor pain induction in fetal death].
Klausch B; Kruse HJ; Junge WD; Göretzlehner G
Zentralbl Gynakol; 1974 Nov; 96(48):1505-13. PubMed ID: 4458350
[TBL] [Abstract][Full Text] [Related]
15. Induction of labour with sulprostone after foetal death and in hydatidiform mole.
Saarikoski S; Selander K; Pystynen P
Prostaglandins; 1980 Sep; 20(3):481-5. PubMed ID: 7422894
[TBL] [Abstract][Full Text] [Related]
16. Induction of dead fetus labor with 15-(S)-methyl prostaglandin F2 alpha.
Miranda JA; Herruzo AJ; Montoya F; Huete A; Mallol MC; Delaorden AF
Int J Gynaecol Obstet; 1988 Apr; 26(2):209-12. PubMed ID: 2898396
[TBL] [Abstract][Full Text] [Related]
17. Termination of pathological pregnancy in second and early third trimesters with extraamniotic instillation of 16-phenoxy-omega-tetranor prostaglandin E2 methylsulfonylamide.
Hwang SF; Chou MM; Ho ES
Int J Gynaecol Obstet; 1994 Nov; 47(2):157-61. PubMed ID: 7843486
[TBL] [Abstract][Full Text] [Related]
18. Termination of normal and pathological pregnancy with Sulprostone.
Fischer Z; Chwalisz K; Michałkiewicz W
Acta Chir Hung; 1986; 27(3):151-6. PubMed ID: 3825407
[TBL] [Abstract][Full Text] [Related]
19. Uterine motility after post-partum application of sulprostone and other oxytocics.
Baumgarten K; Schmidt J; Horvat A; Neumann M; Cerwenka R; Gruber W; Gödicke HD; Grünberger W; Spona J
Eur J Obstet Gynecol Reprod Biol; 1983 Nov; 16(3):181-92. PubMed ID: 6662263
[TBL] [Abstract][Full Text] [Related]
20. Uterine hyperstimulation resulting from intravaginal prostaglandin E2. A case report.
Chamberlin RO; Cohen GR; Knuppel RA
J Reprod Med; 1987 Mar; 32(3):233-5. PubMed ID: 3471969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
